Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Treatt warns on profits, shares tumble

(Sharecast News) - Treatt tumbled on Thursday as it warned on profits, noting a drop in second-quarter sales. In an update for the year to 30 September, the company - which makes natural extracts and ingredients for the beverage, flavour and fragrance industries - said it has continued to face trading headwinds since the interim results in May.

As a result, it now expects revenue of between £130m and £135m and profit before tax and exceptionals of between £9m and £11m. This is down from previous guidance of £146m to £153m and £16m to £18m, respectively.

Treatt said the revised outlook has been driven by a reduction in second-half sales, with revenue now expected to be £66m, compared with previous guidance of £82m.

"While we have successfully converted several pipeline opportunities, including encouraging wins with new customers in Premium, this conversion has been slower than anticipated," it said.

It also pointed to lower repeat customer volumes, driven by competitive pressures and North American consumer confidence.

In addition, Treatt said the weaker US dollar exchange rate has resulted in a circa £0.5m profit headwind as a result of translation of USD profits.

Treatt said that lower demand in the Heritage segment and softening demand in the US have persisted.

"Lower demand in Heritage from sustained high citrus oil prices affecting buying patterns, and leading to reformulation," it said.

"Although citrus oil prices have started to reduce more recently, this has continued to impact both short-term buying patterns in value added citrus products and citrus margins. We expect a reduction of this adverse impact as citrus oil pricing normalises."

It added: "Consumer confidence in the US, combined with geopolitical and tariff uncertainty in the US was impacting the overall beverage market in North America. This has persisted, reflected in extended softening of demand."

At 0855 BST, the shares were down 13% at 219.50p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.